Johnson & Johnson (JNJ) stock had a bullish inflow of $52.96 million worth of trades on uptick and an outflow of $45.92 million in downticks on Friday. The total uptick to downtick ratio stood at 1.15. The net money flow into the stock was $7.05 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $9.94 million. $9.94 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. However, Johnson & Johnson (JNJ) stock traded down $0.11 , and reached $118.97, a drop of -0.09% over the previous day. On a weekly basis, the stock is -0.06%, over the previous weeks close.
The company Insiders own 0.11% of Johnson & Johnson shares according to the proxy statements. Institutional Investors own 65.67% of Johnson & Johnson shares. During last six month period, the net percent change held by insiders has seen a change of -18.24%.
In a related news, The officer (Exec VP, Finance; CFO), of Johnson & Johnson, Caruso Dominic J had unloaded 41,146 shares at $125.01 per share in a transaction on July 26, 2016. The total value of transaction was $5,143,661. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Johnson & Johnson (NYSE:JNJ): The stock opened at $119.36 and touched an intraday high of $119.81 on Friday. During the day, the stock corrected to an intraday low of $118.9, however, the bulls stepped in and pushed the price higher to close in the green at $119.32 with a gain of 0.20% for the day. The total traded volume for the day was 5,806,365. The stock had closed at $119.08 in the previous trading session.
Johnson & Johnson (JNJ) : During the past 4 weeks, traders have been relatively bearish on Johnson & Johnson (JNJ), hence the stock is down -3.83% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.27% relative to the S&P 500. The stock has risen by 0.24% in the past week indicating that the buyers are active at lower levels, but the stock is down -3.96% in the past 4 weeks.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.